430 results on '"HALL, SIMON"'
Search Results
2. MP19-08 CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATES IN PI-RADS 3 LESIONS ON MPMRI: RISK STRATIFIED BY PSA DENSITY
3. MP35-16 DISCRIMINATIVE PERFORMANCE OF AUA 2020 MICROSCOPIC HEMATURIA GUIDELINES FOR INTERMEDIATE AND HIGH-RISK PATIENTS IN PREDICTING NEOPLASMS
4. MP35-17 COMPARISON OF A NOVEL RISK CALCULATOR WITH THE AUA 2020 GUIDELINES FOR STRATIFYING UROTHELIAL MALIGNANCY RISK IN PATIENTS WITH MICROSCOPIC HEMATURIA
5. Morphological Control of Crystalline Savolitinib via the Volatile Deep Eutectic Solvent Technique
6. Analysis of England's incident and mental health nursing workforce data 2015–2022
7. Detonation of Fulminating Gold Produces Heterogeneous Gold Nanoparticles
8. New and Unforeseen Crystal Growth Processes for a Metal Oxide
9. Hearing and feeling memories
10. Prostate Cancer Screening
11. Template‐Free Growth of High‐Temperature Superconductor Nanowires
12. Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium
13. 6. Leonard Matlovich: From Military Hero to Gay Rights Poster Boy
14. Template‐Free Growth of High‐Temperature Superconductor Nanowires
15. Translating Mixed Multichannel Electroacoustic Music With Acoustic Soloist to the Personal Stereophonic Listening Space
16. Confronting historical legacies of biological anthropology in South Africa—Restitution, redress and community-centered science: The Sutherland Nine
17. Crystal structures, Hirshfeld analysis, and energy framework analysis of two differently 3′-substituted 4-methylchalcones: 3′-(N=CHC6H4-p-CH3)-4-methylchalcone and 3′-(NHCOCH3)-4-methylchalcone
18. Supplementary Figure SF2 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
19. Supplementary Materials and Methods, Tables ST1-13 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
20. Supplementary Figure SF1 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
21. Supplementary Figure 2 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
22. Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
23. Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
24. Supplementary Figure 2 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
25. Acceptability and feasibility of plasma phosphorylated‐tau181 in two memory services
26. Black Power and the Anti-Vietnam War Movement
27. Gay Liberation and The Spirit of ’68
28. Ten / Gay Liberation and The Spirit of ’68
29. Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium (Preprint)
30. Preparation and degradation of high air stability sulfide solid electrolyte 75Li2S·25P2S5 glass-ceramic
31. The crystal structure and electronic properties of three novel charge transfer co-crystals TCNQFn–triphenylene (n = 0, 2, 4)
32. True molecular conformation and structure determination by three-dimensional electron diffraction of PAH by-products potentially useful for electronic applications
33. Improved air-stability and conductivity in the 75Li2S·25P2S5 solid-state electrolyte system: the role of Li7P3S11
34. Rapid sol–gel synthesis of honeycomb-layered Na3Ni2BiO6 and orthorhombic Na3Ca2BiO6
35. Author Response
36. MP43-02 PREFERENCE ELICITATION AND TREATMENT DECISION MAKING AMONG MEN DIAGNOSED WITH LOCALIZED PROSTATE CANCER: RESULTS FROM THE HEALIUM TRIAL
37. MP53-12 HOW DO PSA-BASED MARKERS PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA) ON PROSTATE BIOPSY INDEPENDENT OF PROSTATE SIZE
38. PD14-03 ANALYSIS OF TWO INDEPENDENT RISK STRATIFICATION EVALUATION TOOLS IN A COHORT OF PATIENTS WITH MICROSCOPIC HEMATURIA
39. MP58-04 PSA DENSITY DIRECTLY CORRELATES WITH PI-RADS LESION SCORE ON PROSTATE MRI
40. Ethical Considerations for the Workup of the Microhematuria Patient. Letter.
41. MP40-01 COST AND DIAGNOSTIC YIELD OF UPPER TRACT IMAGING IN HIGH RISK MICROHEMATURIA; ARE WE STILL DOING TOO MUCH?
42. PD14-02 CRITICAL EVALUATION OF THE 2020 MICROHEMATURIA GUIDELINES: ARE WE STILL WORKING UP TOO MANY PATIENTS?
43. MP28-03 EVALUATING AN INFORMED/SHARED DECISION-MAKING PROGRAM FOR PROSTATE CANCER SCREENING AMONG MEMBERS OF THE WORLD TRADE CENTER HEALTH PROGRAM: RESULTS FROM AN IMPLEMENTATION STUDY
44. PD19-07 ARE PATIENTS STENTED FOR SEPTIC URETERAL STONES MORE LIKELY TO EXPERIENCE INFECTIOUS COMPLICATIONS AT TIME OF DEFINITIVE MANAGEMENT THAN THOSE STENTED FOR NON-INFECTIOUS INDICATIONS?
45. Yielding to stress in Pickering emulsions at dilute and intermediate volume fractions
46. Two New Organic Co-Crystals Based on Acetamidophenol Molecules
47. Organic Cocrystals of TCNQ and TCNB Based on an Orthocetamol Backbone Solved by Three-Dimensional Electron Diffraction
48. Determining nanorod dimensions in dispersion with size anisotropy nanoparticle tracking analysis
49. Synthesis of porous high-temperature superconductors via a melamine formaldehyde sacrificial template
50. Preparation of High Air Stability Sulfide Electrolyte 75li2s·25p2s5 Glass-Ceramic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.